Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1092346

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1092346

Global Cancer Biomarkers Market Size, Share & Industry Trends Analysis Report By Profiling Technologies, By Application, By Type, By Cancer Type, By Regional Outlook and Forecast, 2022 - 2028

PUBLISHED:
PAGES: 325 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

The Global Cancer Biomarkers Market size is expected to reach $34.3 billion by 2028, rising at a market growth of 16.8% CAGR during the forecast period.

Cancer biomarkers are chemicals or molecules that can be traced and indicate the presence of malignant cells in the body. Cancer prevention involves diagnosing and proteins evaluating multiple cancer biomarkers using various diagnostic procedures in order to obtain timely treatment outcomes. Biomarkers include peptides, proteins, antibodies, and nucleic acids, among others. The presence of these biomarkers in tissues, urine, serum, blood, and other body fluids indicates the presence of a disease or an aberrant process. Various cancer biomarkers have been investigated and are employed as diagnostic, prognostic, personalized therapy, and surrogate endpoint biomarkers. Various businesses, like healthcare and pharmaceuticals, rely on the detection of various types of biomarkers.

One of the major factors expected to boost the cancer biomarkers market growth is research collaborations between various institutes and key industry players with the goal of developing biomarkers for disease diagnosis. For example, in May 2019, Biotech Support Group (BSG) and Leiden University Medical Center (LUMC) announced a research collaboration with the goal of developing stromal conditioning biomarkers in cancer (protein biomarkers).

The greater incidence of cancer globally, as well as the higher acceptance of cancer treatments in developing regions, the paradigm shift in healthcare from disease diagnosis to risk assessment or early diagnosis, and the increasing use of biomarkers in drug development, are all factors driving the market growth. Cancer is the second biggest cause of mortality worldwide, as per the World Health Organization (WHO) 2018 report, with an estimated 9.6 million deaths in 2018. Cancer is responsible for around 1 in every 6 deaths worldwide. 70% of these deaths occur in low and middle income countries. Biomarkers play a critical role in risk assessment, early diagnosis, and effective treatment monitoring; therefore, the market is likely to grow as the prevalence of many lifestyle illnesses rises.

The National Cancer Institute (NCI) invested in March 2016 to establish laboratories for biomarker and biomarker assay research for malignancies of the breast, prostate, lung, and genitourinary organs, as well as cancers with a high incidence rate. Mr. Liangren Li, an Auckland entrepreneur, and his family gave the University of Auckland a grant in April 2016 to perform cancer biomarker research. The money will be used to start the PROSPER project (Profiling of Oncology Patients in Clinical Care and Research).

COVID-19 Impact

The novel coronavirus (covid-19, sars-cov-2) was once assumed to be predominantly a respiratory disease, but as more individuals got the virus, it became obvious that it had a wide range of physiological effects. Covid-19 has an effect on the cardiovascular system and can create difficulties in the brain, kidney, and other organs in addition to the lungs. A multidisciplinary care team is frequently required for critical patients. COVID patients with comorbidities were also more likely to experience severe symptoms that necessitated hospitalization. Despite this, COVID patients with pre-existing cardiovascular problems have the highest fatality rate.

Market Growth Factors

Personalized medicine for cancer treatment

One of the primary factors expected to drive demand for cancer biomarkers is a paradigm shift toward personalized medicine for cancer therapy due to a lack of conventional diagnosis and treatment. Biomarkers are also becoming more important in personalized medicine, with applications in diagnosis, prognosis, and the selection of targeted therapy. Collaborations between various key industry companies and research institutes with the goal of developing novel cancer biomarkers for personalized treatment are also expected to boost market expansion over the forecast period.

The growing incidence of cancer

Companion diagnostics, tailored medications, and other disease diagnostics, such as disease risk assessment and drug research and development, all rely heavily on cancer biomarkers. One of the primary reasons likely to boost cancer biomarkers market growth during the upcoming years is the increased utilization of biomarkers in disease diagnosis. The rising global prevalence of cancer is driving the need for early disease detection, which is propelling the cancer biomarker market forward. According to the National Cancer Institute, 1,735,350 new cancer cases were reported in the United States in 2018.

Market Restraining Factors

Shortage of reimbursement policies for biomarker testing

Despite the rising global incidence of cancer and the increasing number of patients requiring diagnostic tests, the lack of reimbursement regulations for biomarker tests in emerging and industrialized nations is one issue restricting demand for these biomarkers. One of the most important concerns for service providers is sample collection, which is followed by sample access. These samples must be subjected to stringent quality control, and they must be maintained in the proper conditions to avoid loss. Various samples are also necessary for risk detection, screening, diagnosis, and monitoring.

Profiling Technologies Outlook

Based on Profiling Technologies, the market is segmented into Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, and Cytogenetics. The imaging technologies segment garnered a significant revenue share in the cancer biomarker market in 2021. Imaging biomarkers (IBs) are important for the treatment of patients suffering from cancer. Clinical TNM stage, objective response, and left ventricular ejection fraction are all IBs utilized in cancer on a daily basis. Other biomarkers like CT, MRI, PET, and ultrasonography are widely employed in cancer research and medication development. By bridging 'translational gaps' through validation and qualification, new IBs can be produced as effective instruments for testing research ideas in clinical trials & research studies, or as clinical decision-making tools for use in healthcare.

Application Outlook

Based on Application, the market is segmented into Diagnostics, Research & Development, Prognostics, Risk Assessment, and Others. The diagnostics segment acquired the highest revenue share in the cancer biomarker market in 2021. The utilization of cancer biomarkers in drug discovery and development, as well as increased R&D on cancer biomarkers, are driving this segment's growth.

Type Outlook

Based on Type, the market is segmented into Protein, Genetic, and Others. The genetic segment garnered a significant revenue share in the cancer biomarker market in 2021. This is due to its accuracy in predicting cancer stage, detecting cancer recurrence, and monitoring therapy success. Biomarkers can also be detected in non-invasively collected biofluids such as blood or serum, allowing for speedier cancer diagnosis, early detection, and screening. Additionally, cancer biomarkers can be used to improve understanding of efficacy, drug metabolism, pharmacological action, and safety by being subjected to dynamic modification.

Cancer Type Outlook

Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Thyroid Cancer, Melanoma & Leukemia, Kidney & Bladder Cancer, Non-Hodgkin's Lymphoma, Prostate Cancer, and Others. The breast cancer segment acquired the highest revenue share in the cancer biomarker market in 2021.Breast cancer is more common than other types of cancer, such as prostate and stomach cancer. It took the lives of many people last year. Additionally, because oestrogen and progesterone growth hormones are always exposed to female breast cells, it is more popular among women than men. Obesity in females, on the other hand, plays a role in the progression of breast cancer cases. Obesity prevalence, on the other hand, varies greatly from country to country.

Regional Outlook Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The North American region acquired the largest revenue share in the cancer biomarker market in 2021. The expanding R&D on cancer biomarkers and rising technological breakthroughs in the development of cancer biomarkers are driving the growth of the North American cancer biomarkers market. The number of cancer patients in the United States has increased dramatically. According to the American Cancer Society, there were 1,735,350 new cancer cases identified and 609,640 cancer-related deaths in the United States in 2018. Lung cancer, breast cancer, colorectum cancer, cancer, bladder cancer, and skin cancer are the most frequent malignancies in the United States.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Agilent Technologies, Inc., and Merck & Co., Inc.

Strategies deployed in Cancer Biomarkers Market

Dec-2021: Hoffmann-La Roche introduced the research use only (RUO) of 3 new automated digital pathology algorithms, uPath ER (SP1), uPath Ki-67 (30-9), & uPath PR (1E2) image analysis. These analyses are for breast cancer images to produce actionable assessments of scanned slide images that are objective & reproducible, helping pathologists in the counting of these breast cancer markers.

Jul-2021: QIAGEN came into a partnership with Japan's Sysmex Corporation for the development & commercialization of cancer companion diagnostics, which would improve both QIAGEN's leadership in this field & Sysmex's Plasma-Safe-SeqS technology for Next-generation sequencing (NGS). This partnership aimed to build collaborations with pharmaceutical companies for the development of drug treatments for cancer & promote early clinical adoption of ultra-sensitive liquid biopsy companion diagnostics.

Mar-2021: Hoffmann-La Roche released the DISCOVERY Green HRP kit 1. It is the overall collection of modular-based detection kits to identify & profile biomarkers and cell populations in tissue-based research. The innovative DISCOVERY chromogens have translucent properties that allow researchers to analyze the co-localization of various biomarkers through the spatial overlapping of two signals in the terms of tissue.

Oct-2020: Agilent Technologies joined hands with InterVenn, a biotechnology company. This collaboration aimed at the diseases common in Southeast Asia, and the premises for this development work would be at InterVenn Malaysia's laboratory located at Technology Park Malaysia in KL.

Sep-2020: Thermo Fisher Scientific joined hands with AstraZenca, a big name in pharmaceutical and the University of Nebraska Medical Center (UNMC). This collaboration aimed to enhance unique solutions to deal with requirements that weren't met before in clinical biomarker discovery. These solutions would assist streamline the transition from biomarker research to clinical implementation, making the path for new opportunities in precision medicine.

Mar-2020: Thermo Fisher Scientific came into an agreement with Janessen Biotech, one of the subsidiaries of Janssen Pharmaceutical Companies of Johnson & Johnson. This agreement aimed to co-develop a companion diagnostic (CDx) in oncology. The CDx would aid the clinical trial enrollment globally. In this agreement, Thermo Fisher Scientific would join hands with Janssen Research & Development scientists to validate the multiple biomarkers for use with Thermo Fisher's Oncomine Dx Target Test, which would be utilized to detect variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer (NSCLC). In addition, indications in oncology may follow as part of the agreement.

May-2019: QIAGEN introduced the therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit). This product would help in detecting breast cancer patients eligible for treatment with PIQRAY (alpelisib), a newly approved therapy developed & marketed by Novartis. The therascreenPIK3CA Kit is the first companion diagnostic assay to receive premarket approval from the U.S. Food and Drug Administration (FDA) for use in any cancer indication for detection of activating mutations in the PIK3CA gene. It is the first FDA-approved assay for guiding treatment decisions in breast cancer with the use of plasma specimens as a liquid biopsy.

Dec-2018: Hoffman-La Roche came into partnership with Merck, an American multinational pharmaceutical company. This partnership aimed to develop a pan-cancer companion diagnostic to detect advanced solid tumor patients who need anti-PD-1 therapy. Both the companies would broaden the usage of this panel to comprise the identification of patients with solid tumors who can undergo immunotherapy. The new IHC companion diagnostic is being developed for usage on the Roche BenchMark ULTRA instrument. In addition, Roche looked for FDA approval to use the biomarker panel as a standardized predictive testing option for dMMR.

Apr-2018: BioMerieux signed an agreement of acquisition with Astute Medical, a company focused on enhancing the diagnosis of high-risk medical conditions & diseases through the identification & validation of protein biomarkers. This acquisition aimed to develop & market the NEPHROCHECK test for the VIDAS automated immunoassay system. Since 2017, bioMerieux has been a licensed distributor with Astute for the NEPHROCHECK test on the Astute140 Meter in the US.

Scope of the Study

Market Segments covered in the Report:

By Profiling Technologies

  • Omics Technologies
  • Imaging Technologies
  • Immunoassay
  • Bioinformatics
  • Cytogenetics

By Application

  • Diagnostics
  • Research & Development
  • Prognostics
  • Risk Assessment
  • Others

By Type

  • Protein
  • Genetic
  • Others

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Thyroid Cancer
  • Melanoma & Leukemia
  • Kidney & Bladder Cancer
  • Non-Hodgkin's Lymphoma
  • Prostate Cancer
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Merck & Co., Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cancer Biomarkers Market, by Profiling Technologies
    • 1.4.2 Global Cancer Biomarkers Market, by Application
    • 1.4.3 Global Cancer Biomarkers Market, by Type
    • 1.4.4 Global Cancer Biomarkers Market, by Cancer Type
    • 1.4.5 Global Cancer Biomarkers Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Cancer Biomarkers Market

Chapter 4. Global Cancer Biomarkers Market by Profiling Technologies

  • 4.1 Global Omics Technologies Market by Region
  • 4.2 Global Imaging Technologies Market by Region
  • 4.3 Global Immunoassay Market by Region
  • 4.4 Global Bioinformatics Market by Region
  • 4.5 Global Cytogenetics Market by Region

Chapter 5. Global Cancer Biomarkers Market by Application

  • 5.1 Global Diagnostics Market by Region
  • 5.2 Global Research & Development Market by Region
  • 5.3 Global Prognostics Market by Region
  • 5.4 Global Risk Assessment Market by Region
  • 5.5 Global Others Market by Region

Chapter 6. Global Cancer Biomarkers Market by Type

  • 6.1 Global Protein Market by Region
  • 6.2 Global Genetic Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global Cancer Biomarkers Market by Cancer Type

  • 7.1 Global Breast Cancer Market by Region
  • 7.2 Global Lung Cancer Market by Region
  • 7.3 Global Colorectal Cancer Market by Region
  • 7.4 Global Thyroid Cancer Market by Region
  • 7.5 Global Melanoma & Leukemia Market by Region
  • 7.6 Global Kidney & Bladder Cancer Market by Region
  • 7.7 Global Non-Hodgkin's Lymphoma Market by Region
  • 7.8 Global Prostate Cancer Market by Region
  • 7.9 Global Others Market by Region

Chapter 8. Global Cancer Biomarkers Market by Region

  • 8.1 North America Cancer Biomarkers Market
    • 8.1.1 North America Cancer Biomarkers Market by Profiling Technologies
      • 8.1.1.1 North America Omics Technologies Market by Country
      • 8.1.1.2 North America Imaging Technologies Market by Country
      • 8.1.1.3 North America Immunoassay Market by Country
      • 8.1.1.4 North America Bioinformatics Market by Country
      • 8.1.1.5 North America Cytogenetics Market by Country
    • 8.1.2 North America Cancer Biomarkers Market by Application
      • 8.1.2.1 North America Diagnostics Market by Country
      • 8.1.2.2 North America Research & Development Market by Country
      • 8.1.2.3 North America Prognostics Market by Country
      • 8.1.2.4 North America Risk Assessment Market by Country
      • 8.1.2.5 North America Others Market by Country
    • 8.1.3 North America Cancer Biomarkers Market by Type
      • 8.1.3.1 North America Protein Market by Country
      • 8.1.3.2 North America Genetic Market by Country
      • 8.1.3.3 North America Others Market by Country
    • 8.1.4 North America Cancer Biomarkers Market by Cancer Type
      • 8.1.4.1 North America Breast Cancer Market by Country
      • 8.1.4.2 North America Lung Cancer Market by Country
      • 8.1.4.3 North America Colorectal Cancer Market by Country
      • 8.1.4.4 North America Thyroid Cancer Market by Country
      • 8.1.4.5 North America Melanoma & Leukemia Market by Country
      • 8.1.4.6 North America Kidney & Bladder Cancer Market by Country
      • 8.1.4.7 North America Non-Hodgkin's Lymphoma Market by Country
      • 8.1.4.8 North America Prostate Cancer Market by Country
      • 8.1.4.9 North America Others Market by Country
    • 8.1.5 North America Cancer Biomarkers Market by Country
      • 8.1.5.1 US Cancer Biomarkers Market
        • 8.1.5.1.1 US Cancer Biomarkers Market by Profiling Technologies
        • 8.1.5.1.2 US Cancer Biomarkers Market by Application
        • 8.1.5.1.3 US Cancer Biomarkers Market by Type
        • 8.1.5.1.4 US Cancer Biomarkers Market by Cancer Type
      • 8.1.5.2 Canada Cancer Biomarkers Market
        • 8.1.5.2.1 Canada Cancer Biomarkers Market by Profiling Technologies
        • 8.1.5.2.2 Canada Cancer Biomarkers Market by Application
        • 8.1.5.2.3 Canada Cancer Biomarkers Market by Type
        • 8.1.5.2.4 Canada Cancer Biomarkers Market by Cancer Type
      • 8.1.5.3 Mexico Cancer Biomarkers Market
        • 8.1.5.3.1 Mexico Cancer Biomarkers Market by Profiling Technologies
        • 8.1.5.3.2 Mexico Cancer Biomarkers Market by Application
        • 8.1.5.3.3 Mexico Cancer Biomarkers Market by Type
        • 8.1.5.3.4 Mexico Cancer Biomarkers Market by Cancer Type
      • 8.1.5.4 Rest of North America Cancer Biomarkers Market
        • 8.1.5.4.1 Rest of North America Cancer Biomarkers Market by Profiling Technologies
        • 8.1.5.4.2 Rest of North America Cancer Biomarkers Market by Application
        • 8.1.5.4.3 Rest of North America Cancer Biomarkers Market by Type
        • 8.1.5.4.4 Rest of North America Cancer Biomarkers Market by Cancer Type
  • 8.2 Europe Cancer Biomarkers Market
    • 8.2.1 Europe Cancer Biomarkers Market by Profiling Technologies
      • 8.2.1.1 Europe Omics Technologies Market by Country
      • 8.2.1.2 Europe Imaging Technologies Market by Country
      • 8.2.1.3 Europe Immunoassay Market by Country
      • 8.2.1.4 Europe Bioinformatics Market by Country
      • 8.2.1.5 Europe Cytogenetics Market by Country
    • 8.2.2 Europe Cancer Biomarkers Market by Application
      • 8.2.2.1 Europe Diagnostics Market by Country
      • 8.2.2.2 Europe Research & Development Market by Country
      • 8.2.2.3 Europe Prognostics Market by Country
      • 8.2.2.4 Europe Risk Assessment Market by Country
      • 8.2.2.5 Europe Others Market by Country
    • 8.2.3 Europe Cancer Biomarkers Market by Type
      • 8.2.3.1 Europe Protein Market by Country
      • 8.2.3.2 Europe Genetic Market by Country
      • 8.2.3.3 Europe Others Market by Country
    • 8.2.4 Europe Cancer Biomarkers Market by Cancer Type
      • 8.2.4.1 Europe Breast Cancer Market by Country
      • 8.2.4.2 Europe Lung Cancer Market by Country
      • 8.2.4.3 Europe Colorectal Cancer Market by Country
      • 8.2.4.4 Europe Thyroid Cancer Market by Country
      • 8.2.4.5 Europe Melanoma & Leukemia Market by Country
      • 8.2.4.6 Europe Kidney & Bladder Cancer Market by Country
      • 8.2.4.7 Europe Non-Hodgkin's Lymphoma Market by Country
      • 8.2.4.8 Europe Prostate Cancer Market by Country
      • 8.2.4.9 Europe Others Market by Country
    • 8.2.5 Europe Cancer Biomarkers Market by Country
      • 8.2.5.1 Germany Cancer Biomarkers Market
        • 8.2.5.1.1 Germany Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.1.2 Germany Cancer Biomarkers Market by Application
        • 8.2.5.1.3 Germany Cancer Biomarkers Market by Type
        • 8.2.5.1.4 Germany Cancer Biomarkers Market by Cancer Type
      • 8.2.5.2 UK Cancer Biomarkers Market
        • 8.2.5.2.1 UK Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.2.2 UK Cancer Biomarkers Market by Application
        • 8.2.5.2.3 UK Cancer Biomarkers Market by Type
        • 8.2.5.2.4 UK Cancer Biomarkers Market by Cancer Type
      • 8.2.5.3 France Cancer Biomarkers Market
        • 8.2.5.3.1 France Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.3.2 France Cancer Biomarkers Market by Application
        • 8.2.5.3.3 France Cancer Biomarkers Market by Type
        • 8.2.5.3.4 France Cancer Biomarkers Market by Cancer Type
      • 8.2.5.4 Russia Cancer Biomarkers Market
        • 8.2.5.4.1 Russia Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.4.2 Russia Cancer Biomarkers Market by Application
        • 8.2.5.4.3 Russia Cancer Biomarkers Market by Type
        • 8.2.5.4.4 Russia Cancer Biomarkers Market by Cancer Type
      • 8.2.5.5 Spain Cancer Biomarkers Market
        • 8.2.5.5.1 Spain Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.5.2 Spain Cancer Biomarkers Market by Application
        • 8.2.5.5.3 Spain Cancer Biomarkers Market by Type
        • 8.2.5.5.4 Spain Cancer Biomarkers Market by Cancer Type
      • 8.2.5.6 Italy Cancer Biomarkers Market
        • 8.2.5.6.1 Italy Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.6.2 Italy Cancer Biomarkers Market by Application
        • 8.2.5.6.3 Italy Cancer Biomarkers Market by Type
        • 8.2.5.6.4 Italy Cancer Biomarkers Market by Cancer Type
      • 8.2.5.7 Rest of Europe Cancer Biomarkers Market
        • 8.2.5.7.1 Rest of Europe Cancer Biomarkers Market by Profiling Technologies
        • 8.2.5.7.2 Rest of Europe Cancer Biomarkers Market by Application
        • 8.2.5.7.3 Rest of Europe Cancer Biomarkers Market by Type
        • 8.2.5.7.4 Rest of Europe Cancer Biomarkers Market by Cancer Type
  • 8.3 Asia Pacific Cancer Biomarkers Market
    • 8.3.1 Asia Pacific Cancer Biomarkers Market by Profiling Technologies
      • 8.3.1.1 Asia Pacific Omics Technologies Market by Country
      • 8.3.1.2 Asia Pacific Imaging Technologies Market by Country
      • 8.3.1.3 Asia Pacific Immunoassay Market by Country
      • 8.3.1.4 Asia Pacific Bioinformatics Market by Country
      • 8.3.1.5 Asia Pacific Cytogenetics Market by Country
    • 8.3.2 Asia Pacific Cancer Biomarkers Market by Application
      • 8.3.2.1 Asia Pacific Diagnostics Market by Country
      • 8.3.2.2 Asia Pacific Research & Development Market by Country
      • 8.3.2.3 Asia Pacific Prognostics Market by Country
      • 8.3.2.4 Asia Pacific Risk Assessment Market by Country
      • 8.3.2.5 Asia Pacific Others Market by Country
    • 8.3.3 Asia Pacific Cancer Biomarkers Market by Type
      • 8.3.3.1 Asia Pacific Protein Market by Country
      • 8.3.3.2 Asia Pacific Genetic Market by Country
      • 8.3.3.3 Asia Pacific Others Market by Country
    • 8.3.4 Asia Pacific Cancer Biomarkers Market by Cancer Type
      • 8.3.4.1 Asia Pacific Breast Cancer Market by Country
      • 8.3.4.2 Asia Pacific Lung Cancer Market by Country
      • 8.3.4.3 Asia Pacific Colorectal Cancer Market by Country
      • 8.3.4.4 Asia Pacific Thyroid Cancer Market by Country
      • 8.3.4.5 Asia Pacific Melanoma & Leukemia Market by Country
      • 8.3.4.6 Asia Pacific Kidney & Bladder Cancer Market by Country
      • 8.3.4.7 Asia Pacific Non-Hodgkin's Lymphoma Market by Country
      • 8.3.4.8 Asia Pacific Prostate Cancer Market by Country
      • 8.3.4.9 Asia Pacific Others Market by Country
    • 8.3.5 Asia Pacific Cancer Biomarkers Market by Country
      • 8.3.5.1 China Cancer Biomarkers Market
        • 8.3.5.1.1 China Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.1.2 China Cancer Biomarkers Market by Application
        • 8.3.5.1.3 China Cancer Biomarkers Market by Type
        • 8.3.5.1.4 China Cancer Biomarkers Market by Cancer Type
      • 8.3.5.2 Japan Cancer Biomarkers Market
        • 8.3.5.2.1 Japan Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.2.2 Japan Cancer Biomarkers Market by Application
        • 8.3.5.2.3 Japan Cancer Biomarkers Market by Type
        • 8.3.5.2.4 Japan Cancer Biomarkers Market by Cancer Type
      • 8.3.5.3 India Cancer Biomarkers Market
        • 8.3.5.3.1 India Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.3.2 India Cancer Biomarkers Market by Application
        • 8.3.5.3.3 India Cancer Biomarkers Market by Type
        • 8.3.5.3.4 India Cancer Biomarkers Market by Cancer Type
      • 8.3.5.4 South Korea Cancer Biomarkers Market
        • 8.3.5.4.1 South Korea Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.4.2 South Korea Cancer Biomarkers Market by Application
        • 8.3.5.4.3 South Korea Cancer Biomarkers Market by Type
        • 8.3.5.4.4 South Korea Cancer Biomarkers Market by Cancer Type
      • 8.3.5.5 Singapore Cancer Biomarkers Market
        • 8.3.5.5.1 Singapore Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.5.2 Singapore Cancer Biomarkers Market by Application
        • 8.3.5.5.3 Singapore Cancer Biomarkers Market by Type
        • 8.3.5.5.4 Singapore Cancer Biomarkers Market by Cancer Type
      • 8.3.5.6 Malaysia Cancer Biomarkers Market
        • 8.3.5.6.1 Malaysia Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.6.2 Malaysia Cancer Biomarkers Market by Application
        • 8.3.5.6.3 Malaysia Cancer Biomarkers Market by Type
        • 8.3.5.6.4 Malaysia Cancer Biomarkers Market by Cancer Type
      • 8.3.5.7 Rest of Asia Pacific Cancer Biomarkers Market
        • 8.3.5.7.1 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies
        • 8.3.5.7.2 Rest of Asia Pacific Cancer Biomarkers Market by Application
        • 8.3.5.7.3 Rest of Asia Pacific Cancer Biomarkers Market by Type
        • 8.3.5.7.4 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type
  • 8.4 LAMEA Cancer Biomarkers Market
    • 8.4.1 LAMEA Cancer Biomarkers Market by Profiling Technologies
      • 8.4.1.1 LAMEA Omics Technologies Market by Country
      • 8.4.1.2 LAMEA Imaging Technologies Market by Country
      • 8.4.1.3 LAMEA Immunoassay Market by Country
      • 8.4.1.4 LAMEA Bioinformatics Market by Country
      • 8.4.1.5 LAMEA Cytogenetics Market by Country
    • 8.4.2 LAMEA Cancer Biomarkers Market by Application
      • 8.4.2.1 LAMEA Diagnostics Market by Country
      • 8.4.2.2 LAMEA Research & Development Market by Country
      • 8.4.2.3 LAMEA Prognostics Market by Country
      • 8.4.2.4 LAMEA Risk Assessment Market by Country
      • 8.4.2.5 LAMEA Others Market by Country
    • 8.4.3 LAMEA Cancer Biomarkers Market by Type
      • 8.4.3.1 LAMEA Protein Market by Country
      • 8.4.3.2 LAMEA Genetic Market by Country
      • 8.4.3.3 LAMEA Others Market by Country
    • 8.4.4 LAMEA Cancer Biomarkers Market by Cancer Type
      • 8.4.4.1 LAMEA Breast Cancer Market by Country
      • 8.4.4.2 LAMEA Lung Cancer Market by Country
      • 8.4.4.3 LAMEA Colorectal Cancer Market by Country
      • 8.4.4.4 LAMEA Thyroid Cancer Market by Country
      • 8.4.4.5 LAMEA Melanoma & Leukemia Market by Country
      • 8.4.4.6 LAMEA Kidney & Bladder Cancer Market by Country
      • 8.4.4.7 LAMEA Non-Hodgkin's Lymphoma Market by Country
      • 8.4.4.8 LAMEA Prostate Cancer Market by Country
      • 8.4.4.9 LAMEA Others Market by Country
    • 8.4.5 LAMEA Cancer Biomarkers Market by Country
      • 8.4.5.1 Brazil Cancer Biomarkers Market
        • 8.4.5.1.1 Brazil Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.1.2 Brazil Cancer Biomarkers Market by Application
        • 8.4.5.1.3 Brazil Cancer Biomarkers Market by Type
        • 8.4.5.1.4 Brazil Cancer Biomarkers Market by Cancer Type
      • 8.4.5.2 Argentina Cancer Biomarkers Market
        • 8.4.5.2.1 Argentina Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.2.2 Argentina Cancer Biomarkers Market by Application
        • 8.4.5.2.3 Argentina Cancer Biomarkers Market by Type
        • 8.4.5.2.4 Argentina Cancer Biomarkers Market by Cancer Type
      • 8.4.5.3 UAE Cancer Biomarkers Market
        • 8.4.5.3.1 UAE Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.3.2 UAE Cancer Biomarkers Market by Application
        • 8.4.5.3.3 UAE Cancer Biomarkers Market by Type
        • 8.4.5.3.4 UAE Cancer Biomarkers Market by Cancer Type
      • 8.4.5.4 Saudi Arabia Cancer Biomarkers Market
        • 8.4.5.4.1 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.4.2 Saudi Arabia Cancer Biomarkers Market by Application
        • 8.4.5.4.3 Saudi Arabia Cancer Biomarkers Market by Type
        • 8.4.5.4.4 Saudi Arabia Cancer Biomarkers Market by Cancer Type
      • 8.4.5.5 South Africa Cancer Biomarkers Market
        • 8.4.5.5.1 South Africa Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.5.2 South Africa Cancer Biomarkers Market by Application
        • 8.4.5.5.3 South Africa Cancer Biomarkers Market by Type
        • 8.4.5.5.4 South Africa Cancer Biomarkers Market by Cancer Type
      • 8.4.5.6 Nigeria Cancer Biomarkers Market
        • 8.4.5.6.1 Nigeria Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.6.2 Nigeria Cancer Biomarkers Market by Application
        • 8.4.5.6.3 Nigeria Cancer Biomarkers Market by Type
        • 8.4.5.6.4 Nigeria Cancer Biomarkers Market by Cancer Type
      • 8.4.5.7 Rest of LAMEA Cancer Biomarkers Market
        • 8.4.5.7.1 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies
        • 8.4.5.7.2 Rest of LAMEA Cancer Biomarkers Market by Application
        • 8.4.5.7.3 Rest of LAMEA Cancer Biomarkers Market by Type
        • 8.4.5.7.4 Rest of LAMEA Cancer Biomarkers Market by Cancer Type

Chapter 9. Company Profiles

  • 9.1 BioMerieux S.A.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Acquisition and Mergers:
  • 9.2 F. Hoffmann-La Roche Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
  • 9.3 Becton, Dickinson and Company
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
  • 9.4 Abbott Laboratories
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
  • 9.5 Thermo Fisher Scientific, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
    • 9.5.6 SWOT Analysis
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
  • 9.7 Bio-Rad laboratories, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
  • 9.8 Qiagen N.V.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Partnerships, Collaborations, and Agreements:
      • 9.8.5.2 Product Launches and Product Expansions:
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
  • 9.10. Merck & Co., Inc. (Merck Millipore)
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Global Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 2 Global Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 3 Global Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 4 Global Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 5 Global Omics Technologies Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Omics Technologies Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Imaging Technologies Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Imaging Technologies Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Immunoassay Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Immunoassay Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Bioinformatics Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Bioinformatics Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Cytogenetics Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Cytogenetics Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 16 Global Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 17 Global Diagnostics Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Diagnostics Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Research & Development Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Research & Development Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Prognostics Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Prognostics Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Risk Assessment Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Risk Assessment Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 28 Global Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 29 Global Protein Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Protein Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Genetic Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Genetic Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 36 Global Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 37 Global Breast Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Breast Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Lung Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 40 Global Lung Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 41 Global Colorectal Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 42 Global Colorectal Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 43 Global Thyroid Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 44 Global Thyroid Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 45 Global Melanoma & Leukemia Market by Region, 2018 - 2021, USD Million
  • TABLE 46 Global Melanoma & Leukemia Market by Region, 2022 - 2028, USD Million
  • TABLE 47 Global Kidney & Bladder Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 48 Global Kidney & Bladder Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 49 Global Non-Hodgkin's Lymphoma Market by Region, 2018 - 2021, USD Million
  • TABLE 50 Global Non-Hodgkin's Lymphoma Market by Region, 2022 - 2028, USD Million
  • TABLE 51 Global Prostate Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 52 Global Prostate Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 53 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 54 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 55 Global Cancer Biomarkers Market by Region, 2018 - 2021, USD Million
  • TABLE 56 Global Cancer Biomarkers Market by Region, 2022 - 2028, USD Million
  • TABLE 57 North America Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 58 North America Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 59 North America Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 60 North America Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 61 North America Omics Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Omics Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Imaging Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Imaging Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Immunoassay Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Immunoassay Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Bioinformatics Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Bioinformatics Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Cytogenetics Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Cytogenetics Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 72 North America Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 73 North America Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Research & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Research & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 77 North America Prognostics Market by Country, 2018 - 2021, USD Million
  • TABLE 78 North America Prognostics Market by Country, 2022 - 2028, USD Million
  • TABLE 79 North America Risk Assessment Market by Country, 2018 - 2021, USD Million
  • TABLE 80 North America Risk Assessment Market by Country, 2022 - 2028, USD Million
  • TABLE 81 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 82 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 83 North America Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 84 North America Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 85 North America Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 86 North America Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 87 North America Genetic Market by Country, 2018 - 2021, USD Million
  • TABLE 88 North America Genetic Market by Country, 2022 - 2028, USD Million
  • TABLE 89 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 90 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 91 North America Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 92 North America Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 93 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 94 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 95 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 96 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 97 North America Colorectal Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 98 North America Colorectal Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 99 North America Thyroid Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 100 North America Thyroid Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 101 North America Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
  • TABLE 102 North America Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
  • TABLE 103 North America Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 104 North America Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 105 North America Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
  • TABLE 106 North America Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
  • TABLE 107 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 108 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 109 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 110 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 111 North America Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 112 North America Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 113 US Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 114 US Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 115 US Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 116 US Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 117 US Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 118 US Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 119 US Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 120 US Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 121 US Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 122 US Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 123 Canada Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 124 Canada Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 125 Canada Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 126 Canada Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 127 Canada Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 128 Canada Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 129 Canada Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Canada Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Canada Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 132 Canada Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 133 Mexico Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 134 Mexico Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 135 Mexico Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 136 Mexico Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 137 Mexico Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 138 Mexico Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 139 Mexico Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 140 Mexico Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 141 Mexico Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 142 Mexico Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 143 Rest of North America Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 144 Rest of North America Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 145 Rest of North America Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 146 Rest of North America Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 147 Rest of North America Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 148 Rest of North America Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 149 Rest of North America Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 150 Rest of North America Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 151 Rest of North America Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 152 Rest of North America Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 153 Europe Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 154 Europe Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 155 Europe Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 156 Europe Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 157 Europe Omics Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Europe Omics Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Europe Imaging Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Europe Imaging Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
  • TABLE 162 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
  • TABLE 163 Europe Bioinformatics Market by Country, 2018 - 2021, USD Million
  • TABLE 164 Europe Bioinformatics Market by Country, 2022 - 2028, USD Million
  • TABLE 165 Europe Cytogenetics Market by Country, 2018 - 2021, USD Million
  • TABLE 166 Europe Cytogenetics Market by Country, 2022 - 2028, USD Million
  • TABLE 167 Europe Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 168 Europe Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 169 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 170 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 171 Europe Research & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 172 Europe Research & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 173 Europe Prognostics Market by Country, 2018 - 2021, USD Million
  • TABLE 174 Europe Prognostics Market by Country, 2022 - 2028, USD Million
  • TABLE 175 Europe Risk Assessment Market by Country, 2018 - 2021, USD Million
  • TABLE 176 Europe Risk Assessment Market by Country, 2022 - 2028, USD Million
  • TABLE 177 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Europe Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 180 Europe Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 181 Europe Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Europe Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Europe Genetic Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Europe Genetic Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Europe Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 188 Europe Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 189 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Europe Lung Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Europe Lung Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Europe Colorectal Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Europe Colorectal Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Europe Thyroid Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Europe Thyroid Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Europe Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Europe Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Europe Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Europe Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Europe Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Europe Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Europe Prostate Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Europe Prostate Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Europe Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Europe Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Germany Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 210 Germany Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 211 Germany Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 212 Germany Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 213 Germany Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 214 Germany Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 215 Germany Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 216 Germany Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 217 Germany Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 218 Germany Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 219 UK Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 220 UK Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 221 UK Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 222 UK Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 223 UK Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 224 UK Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 225 UK Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 226 UK Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 227 UK Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 228 UK Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 229 France Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 230 France Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 231 France Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 232 France Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 233 France Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 234 France Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 235 France Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 236 France Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 237 France Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 238 France Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 239 Russia Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 240 Russia Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 241 Russia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 242 Russia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 243 Russia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 244 Russia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 245 Russia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 246 Russia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 247 Russia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 248 Russia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 249 Spain Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 250 Spain Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 251 Spain Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 252 Spain Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 253 Spain Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 254 Spain Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 255 Spain Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 256 Spain Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 257 Spain Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 258 Spain Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 259 Italy Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 260 Italy Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 261 Italy Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 262 Italy Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 263 Italy Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 264 Italy Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 265 Italy Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 266 Italy Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 267 Italy Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 268 Italy Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 269 Rest of Europe Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 270 Rest of Europe Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 271 Rest of Europe Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 272 Rest of Europe Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 273 Rest of Europe Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 274 Rest of Europe Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 275 Rest of Europe Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 276 Rest of Europe Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 277 Rest of Europe Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 278 Rest of Europe Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 279 Asia Pacific Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 280 Asia Pacific Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 281 Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 282 Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 283 Asia Pacific Omics Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 284 Asia Pacific Omics Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Asia Pacific Imaging Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 286 Asia Pacific Imaging Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 287 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
  • TABLE 288 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
  • TABLE 289 Asia Pacific Bioinformatics Market by Country, 2018 - 2021, USD Million
  • TABLE 290 Asia Pacific Bioinformatics Market by Country, 2022 - 2028, USD Million
  • TABLE 291 Asia Pacific Cytogenetics Market by Country, 2018 - 2021, USD Million
  • TABLE 292 Asia Pacific Cytogenetics Market by Country, 2022 - 2028, USD Million
  • TABLE 293 Asia Pacific Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 294 Asia Pacific Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 295 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 296 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 297 Asia Pacific Research & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 298 Asia Pacific Research & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 299 Asia Pacific Prognostics Market by Country, 2018 - 2021, USD Million
  • TABLE 300 Asia Pacific Prognostics Market by Country, 2022 - 2028, USD Million
  • TABLE 301 Asia Pacific Risk Assessment Market by Country, 2018 - 2021, USD Million
  • TABLE 302 Asia Pacific Risk Assessment Market by Country, 2022 - 2028, USD Million
  • TABLE 303 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 304 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 305 Asia Pacific Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 306 Asia Pacific Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 307 Asia Pacific Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 308 Asia Pacific Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 309 Asia Pacific Genetic Market by Country, 2018 - 2021, USD Million
  • TABLE 310 Asia Pacific Genetic Market by Country, 2022 - 2028, USD Million
  • TABLE 311 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 312 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 313 Asia Pacific Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 314 Asia Pacific Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 315 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 316 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 317 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 318 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 319 Asia Pacific Colorectal Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 320 Asia Pacific Colorectal Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 321 Asia Pacific Thyroid Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 322 Asia Pacific Thyroid Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 323 Asia Pacific Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
  • TABLE 324 Asia Pacific Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
  • TABLE 325 Asia Pacific Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 326 Asia Pacific Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 327 Asia Pacific Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
  • TABLE 328 Asia Pacific Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
  • TABLE 329 Asia Pacific Prostate Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 330 Asia Pacific Prostate Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 331 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 332 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 333 Asia Pacific Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 334 Asia Pacific Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 335 China Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 336 China Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 337 China Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 338 China Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 339 China Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 340 China Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 341 China Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 342 China Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 343 China Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 344 China Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 345 Japan Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 346 Japan Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 347 Japan Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 348 Japan Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 349 Japan Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 350 Japan Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 351 Japan Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 352 Japan Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 353 Japan Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 354 Japan Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 355 India Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 356 India Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 357 India Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 358 India Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 359 India Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 360 India Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 361 India Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 362 India Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 363 India Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 364 India Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 365 South Korea Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 366 South Korea Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 367 South Korea Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 368 South Korea Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 369 South Korea Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 370 South Korea Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 371 South Korea Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 372 South Korea Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 373 South Korea Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 374 South Korea Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 375 Singapore Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 376 Singapore Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 377 Singapore Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 378 Singapore Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 379 Singapore Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 380 Singapore Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 381 Singapore Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 382 Singapore Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 383 Singapore Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 384 Singapore Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 385 Malaysia Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 386 Malaysia Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 387 Malaysia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 388 Malaysia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 389 Malaysia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 390 Malaysia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 391 Malaysia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 392 Malaysia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 393 Malaysia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 394 Malaysia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 395 Rest of Asia Pacific Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 396 Rest of Asia Pacific Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 397 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 398 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 399 Rest of Asia Pacific Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 400 Rest of Asia Pacific Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 401 Rest of Asia Pacific Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 402 Rest of Asia Pacific Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 403 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 404 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 405 LAMEA Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 406 LAMEA Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 407 LAMEA Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 408 LAMEA Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 409 LAMEA Omics Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 410 LAMEA Omics Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 411 LAMEA Imaging Technologies Market by Country, 2018 - 2021, USD Million
  • TABLE 412 LAMEA Imaging Technologies Market by Country, 2022 - 2028, USD Million
  • TABLE 413 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
  • TABLE 414 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
  • TABLE 415 LAMEA Bioinformatics Market by Country, 2018 - 2021, USD Million
  • TABLE 416 LAMEA Bioinformatics Market by Country, 2022 - 2028, USD Million
  • TABLE 417 LAMEA Cytogenetics Market by Country, 2018 - 2021, USD Million
  • TABLE 418 LAMEA Cytogenetics Market by Country, 2022 - 2028, USD Million
  • TABLE 419 LAMEA Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 420 LAMEA Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 421 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 422 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 423 LAMEA Research & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 424 LAMEA Research & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 425 LAMEA Prognostics Market by Country, 2018 - 2021, USD Million
  • TABLE 426 LAMEA Prognostics Market by Country, 2022 - 2028, USD Million
  • TABLE 427 LAMEA Risk Assessment Market by Country, 2018 - 2021, USD Million
  • TABLE 428 LAMEA Risk Assessment Market by Country, 2022 - 2028, USD Million
  • TABLE 429 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 430 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 431 LAMEA Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 432 LAMEA Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 433 LAMEA Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 434 LAMEA Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 435 LAMEA Genetic Market by Country, 2018 - 2021, USD Million
  • TABLE 436 LAMEA Genetic Market by Country, 2022 - 2028, USD Million
  • TABLE 437 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 438 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 439 LAMEA Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 440 LAMEA Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 441 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 442 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 443 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 444 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 445 LAMEA Colorectal Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 446 LAMEA Colorectal Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 447 LAMEA Thyroid Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 448 LAMEA Thyroid Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 449 LAMEA Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
  • TABLE 450 LAMEA Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
  • TABLE 451 LAMEA Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 452 LAMEA Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 453 LAMEA Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
  • TABLE 454 LAMEA Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
  • TABLE 455 LAMEA Prostate Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 456 LAMEA Prostate Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 457 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 458 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 459 LAMEA Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 460 LAMEA Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 461 Brazil Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 462 Brazil Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 463 Brazil Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 464 Brazil Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 465 Brazil Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 466 Brazil Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 467 Brazil Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 468 Brazil Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 469 Brazil Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 470 Brazil Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 471 Argentina Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 472 Argentina Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 473 Argentina Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 474 Argentina Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 475 Argentina Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 476 Argentina Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 477 Argentina Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 478 Argentina Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 479 Argentina Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 480 Argentina Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 481 UAE Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 482 UAE Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 483 UAE Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 484 UAE Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 485 UAE Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 486 UAE Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 487 UAE Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 488 UAE Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 489 UAE Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 490 UAE Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 491 Saudi Arabia Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 492 Saudi Arabia Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 493 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 494 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 495 Saudi Arabia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 496 Saudi Arabia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 497 Saudi Arabia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 498 Saudi Arabia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 499 Saudi Arabia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 500 Saudi Arabia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 501 South Africa Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 502 South Africa Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 503 South Africa Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 504 South Africa Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 505 South Africa Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 506 South Africa Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 507 South Africa Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 508 South Africa Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 509 South Africa Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 510 South Africa Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 511 Nigeria Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 512 Nigeria Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 513 Nigeria Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 514 Nigeria Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 515 Nigeria Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 516 Nigeria Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 517 Nigeria Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 518 Nigeria Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 519 Nigeria Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 520 Nigeria Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 521 Rest of LAMEA Cancer Biomarkers Market, 2018 - 2021, USD Million
  • TABLE 522 Rest of LAMEA Cancer Biomarkers Market, 2022 - 2028, USD Million
  • TABLE 523 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
  • TABLE 524 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
  • TABLE 525 Rest of LAMEA Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
  • TABLE 526 Rest of LAMEA Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
  • TABLE 527 Rest of LAMEA Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
  • TABLE 528 Rest of LAMEA Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
  • TABLE 529 Rest of LAMEA Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
  • TABLE 530 Rest of LAMEA Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
  • TABLE 531 Key information - BioMerieux S.A.
  • TABLE 532 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 533 Key information - Becton, Dickinson and Company
  • TABLE 534 Key Information - Abbott Laboratories
  • TABLE 535 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 536 key information - Illumina, Inc.
  • TABLE 537 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 538 Key Information - Qiagen N.V.
  • TABLE 539 key Information - Agilent Technologies, Inc.
  • TABLE 540 KEY INFORMATION - MERCK & CO., INC.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Cancer Biomarkers Market Share by Profiling Technologies, 2021
  • FIG 3 Global Cancer Biomarkers Market Share by Profiling Technologies, 2028
  • FIG 4 Global Cancer Biomarkers Market by Profiling Technologies, 2018 - 2028, USD Million
  • FIG 5 Global Cancer Biomarkers Market Share by Application, 2021
  • FIG 6 Global Cancer Biomarkers Market Share by Application, 20128
  • FIG 7 Global Cancer Biomarkers Market by Application, 2018 - 2028, USD Million
  • FIG 8 Global Cancer Biomarkers Market Share by Type, 2021
  • FIG 9 Global Cancer Biomarkers Market Share by Type, 2028
  • FIG 10 Global Cancer Biomarkers Market by Type, 2018 - 2028, USD Million
  • FIG 11 Global Cancer Biomarkers Market Share by Cancer Type, 2021
  • FIG 12 Global Cancer Biomarkers Market Share by Cancer Type, 2028
  • FIG 13 Global Cancer Biomarkers Market by Cancer Type, 2018 - 2028, USD Million
  • FIG 14 Global Cancer Biomarkers Market Share by Region, 2021
  • FIG 15 Global Cancer Biomarkers Market Share by Region, 2028
  • FIG 16 Global Cancer Biomarkers Market by Region, 2018 - 2028, USD Million
  • FIG 17 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 18 Swot analysis: thermo fisher scientific, inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!